Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer-Reference-Cited by-同舟云学术

Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer

Published:2009-10 Issue:10 Volume:9 Page:1429-1434
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Merseburger Axel S,Simon Annika,Waalkes Sandra,Kuczyk Markus A

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/era.09.96

Reference44 articles.

1. Vickers MM, Choueiri TK, Percy Aet al.Failure of initial VEGF-targeted therapy in metastatic renal cell carcinoma (mRCC): what next? Presented at:American Society of Clinical Oncology Annual Meeting. Orlando, FL, USA, 29 May–2 June 2009.

2. Der Stellenwert der Targeted-Therapie beim Nierenzellkarzinom

3. An update on the medical therapy of advanced metastatic renal cell carcinoma

4. Targeted therapies in metastatic renal cancer in 2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic Renal Cell Carcinoma Presenting as a Bleeding Gastric Polyp;Ochsner Journal;2018

2. VEGFR, RET, and RAF/MEK/ERK Pathway Take Part in the Inhibition of Osteosarcoma MG63 Cells with Sorafenib Treatment;Cell Biochemistry and Biophysics;2013-12-31

3. Protein kinase inhibitors in renal cell carcinoma;Expert Opinion on Pharmacotherapy;2013-12-16

4. Sequencing Systemic Therapies in Advanced RCC: Is There a Best Strategy?;American Society of Clinical Oncology Educational Book;2013-05

5. Treatment selection in metastatic renal cell carcinoma: expert consensus;Nature Reviews Clinical Oncology;2012-04-10